Spruce Biosciences, Inc
SPRB
NASDAQ
Biotechnology
$52.64
USD
+2.87 (+5.77%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $136.98M
Volume 42.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics Inc | $163.15M | - | - | - | |
CNTB | Connect Biopharma Holdings Ltd | $159.93M | - | - | - | |
CRBU | Caribou Biosciences Inc | $159.68M | - | +13.0% | - | |
CNTN | Canton Strategic Holdings Inc | $151.93M | - | - | - | |
CBUS | Cibus Inc | $148.47M | - | -9.8% | - | |
HURA | TuHURA Biosciences Inc | $147.11M | - | - | +0.0% | |
UNCY | Unicycive Therapeutics Inc | $137.24M | - | - | - | |
SPRB | Spruce Biosciences, Inc | $136.98M | - | - | - | |
IMDX | Insight Molecular Diagnostics Inc | $131.55M | - | -49.3% | - | |
CUE | Cue Biopharma Inc | $131.26M | - | +309.6% | - | |
EQ | Equillium Inc | $127.40M | - | - | - |
Top Peer by Growth
Cue Biopharma Inc
+309.6% YoY Revenue
Best 1-Year Return
Spruce Biosciences, Inc
+423.0% Return